Main menu


You are here

Home

Boosters

Cases of BQ.1, BQ.1.1 COVID variants double in U.S. as Europe warns of rise

Fri, 2022-10-21 17:12 — mike kraft
Cases of BQ.1, BQ.1.1 COVID variants double in U.S. as Europe warns of rise U.S. regulators estimated BQ.1 and closely related BQ.1.1 accounted for 16.6% of COVID variants in the country, nearly doubling from last week, as Europe expects them to become dominant in a month. Manas Mishra,Khushi Mandowara Reuters

...

Country / Region Tags: 
Europe
Global
United States
General Topic Tags: 
COVID-19
Boosters
Contagion
Demographics
Disease
Disease Prevention
Health
Mutations
Pandemics
Research
Science
Social distancing
Adaptation
Problem, Solution, SitRep, or ?: 
Situation Report

Analysis: Falling demand for COVID boosters makes price hikes more likely

Fri, 2022-10-21 17:06 — mike kraft
Analysis: Falling demand for COVID boosters puts price hikes on the table With most Americans delaying or skipping new COVID-19 booster shots, analysts and investors are now predicting far fewer will be given each year, pushing the number of shots well below annual flu vaccinations. Michael Erman Reuters

...

Country / Region Tags: 
Africa
Europe
Germany
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Attitudes
Public Health
Vaccinations
Economics
Problem, Solution, SitRep, or ?: 
Situation Report

After the USG stops buying the shots, Pfizer says COVID-19 vaccine will cost $110-$130 per dose

Fri, 2022-10-21 13:15 — mike kraft
Pfizer says COVID-19 vaccine will cost $110-$130 per dose Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free. AP NEWS

...

Pfizer executives said the commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying and distributing the shots.

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Health
Vaccinations
Economics
Problem, Solution, SitRep, or ?: 
Situation Report

FDA’s vaccines chief sees possibility of more Covid boosters to iprove protection

Fri, 2022-10-21 10:17 — mike kraft
FDA’s vaccines chief sees possibility of more Covid boosters — sooner than he’d like The FDA’s vaccines chief sees the possibility of more Covid boosters for some people before next fall. Helen Branswell STAT

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Boosters
Treatments
Contagion
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

U.S. panel votes to add COVID shots to recommended vaccinations

Thu, 2022-10-20 16:42 — mike kraft
Panel votes to add COVID shots to recommended vaccinations NEW YORK (AP) — COVID-19 shots should be added to the lists of recommended vaccinations for kids and adults, a panel of U.S. vaccine experts said Thursday. The panel's unanimous decision has no immediate effect — COVID-19 shots already are recommended for virtually all Americans. AP NEWS

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Government
Health
Medical Personnel
Pandemics
Policy
Public Health
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Moderna COVID vaccine safe, comparably effective in preschoolers ---clinical trial

Thu, 2022-10-20 16:35 — mike kraft
Study: Moderna COVID vaccine safe, comparably effective in preschoolers The vaccine in kids 6 months to 5 years triggered similar immune response and protection as in young adults. CIDRAP
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Data
Demographics
Disease
Disease Prevention
Government
Health
Medical Testing
Mutations
Pandemics
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

U.S. committee recommends that CDC add COVID shots to its free vaccine program

Wed, 2022-10-19 17:23 — mike kraft
U.S. committee recommends COVID shot for CDC's free vaccine program An expert committee on Wednesday recommended that COVID-19 shots become part of the U.S. Centers for Disease Control and Prevention's (CDC) vaccine program for children, which provides many types of free inoculations to millions of kids each year. Reuters Reuters

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Demographics
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Policy
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

U.S. FDA authorizes Novavax's COVID vaccine as booster for adults

Wed, 2022-10-19 12:32 — mike kraft
U.S. FDA authorizes Novavax's COVID vaccine as booster for adults The U.S. Food and Drug Administration on Wednesday authorized Novavax Inc's COVID-19 vaccine as a booster for adults, helping the company's shares reverse course and rise more than 3%. Reuters Reuters

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Begining of a trend? Harvard announces new bivalent COVID booster requirement

Wed, 2022-10-19 09:44 — mike kraft
Harvard announces new bivalent COVID booster requirement Are other Mass. schools soon to follow? Clara McCourt Boston.com

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Demographics
Disease
Disease Prevention
Health
Mandates
Mutations
Pandemics
Policy
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Moderna says its Omicron booster response stays high through 3 months

Wed, 2022-10-19 09:34 — mike kraft
Moderna says Omicron booster response stays high through 3 months Moderna Inc said on Wednesday its COVID-19 vaccine booster targeting the BA.1 subvariant of Omicron generated a strong immune response against that variant, with antibody levels staying high for at least three months. Reuters Reuters

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Data
Disease
Disease Prevention
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Boosters
howdy folks
Page loaded in 0.583 seconds.